Spironolactone for maintaining normal heart rhythm
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests if a common blood pressure and heart pill, spironolactone, can help keep your heart in a normal rhythm and prevent atrial fibrillation episodes from coming back. If you have high blood pressure and have had at least one AF episode in the last 6 months, you might be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have high blood pressure and have been taking blood pressure medication for more than 12 months.
- You have had at least one episode of atrial fibrillation (irregular heartbeat) in the last 6 months, but you are in normal heart rhythm right now.
- You are willing to follow the study visit schedule.
- You speak French and are covered by French social security.
- You are not pregnant or breastfeeding, and if you could become pregnant, you agree to use effective birth control during the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a medicine called eplerenone can help prevent atrial fibrillation from coming back in people who also have structural heart disease (changes in the heart's structure). If you have had episodes of irregular heartbeat that stopped, this drug might lower the chance of them returning.
This trial tests whether chloroquine can reduce symptoms in people with persistent atrial fibrillation (AF), an irregular heartbeat that lasts longer than a week. It will also closely monitor heart rhythm and safety, since the medicine can affect the heart and other organs.
This trial tests whether starting spironolactone helps people with heart failure symptoms when the heart pumps “preserved” (not severely reduced). Participants are assigned to start spironolactone or usual care so researchers can see if it improves outcomes.
This trial tests an early treatment approach for people who had a recent ischemic stroke (a stroke caused by a blocked blood vessel) and have an irregular heart rhythm called atrial fibrillation (AF). It aims to lower the chance of having another stroke by treating AF as early as possible after the stroke.
This study tests a new drug called BAY 3670549 to see if it can help convert atrial fibrillation (an irregular heartbeat) back to normal rhythm. You'll receive the study drug or a placebo along with a procedure to restore your heart's normal rhythm, and researchers will monitor how well it works and how safe it is.
This study tests a stepwise treatment plan for people with persistent atrial fibrillation (a long-lasting irregular heartbeat) who also have an enlarged left atrium. It aims to see if a medication called amiodarone plus a cardioversion procedure can help restore normal rhythm.
Hear when a new Atrial Fibrillation Recurrent trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.